MYCOLab Ai Logo - gold and army green

Genome Sequencing Illustrates the Genetic Basis of the Pharmacological Properties of Gloeostereum incarnatum

Summary

This research provides the first complete genetic blueprint of Gloeostereum incarnatum, an important medicinal mushroom. The study reveals how this fungus produces beneficial compounds that give it medicinal properties. Understanding the genetics behind these processes could help develop new medicines and improve mushroom cultivation. Impacts on everyday life: • Could lead to more efficient production of natural medicines from mushrooms • May help develop new therapeutic treatments for various diseases • Could improve cultivation methods for medicinal mushrooms • Helps understand how fungi produce beneficial compounds • May lead to discovery of new pharmaceutical compounds

Background

Gloeostereum incarnatum is a precious edible mushroom widely grown in Asia and known for its medicinal properties including antioxidant, immunomodulatory, anti-inflammatory, anti-proliferative and antibacterial effects. Recent studies have shown that sesquiterpenes and polysaccharides are the main bioactive compounds underlying its beneficial effects.

Objective

To present a high-quality reference genome for G. incarnatum and identify relevant functional genes, gene clusters, and signaling pathways associated with its saprophytic lifestyle and pharmaceutical properties, with specific focus on terpene biosynthesis, cytochrome P450 enzyme biosynthesis, and polysaccharide production.

Results

The assembled G. incarnatum genome was 38.67 Mbp with an N50 of 3.5 Mbp, encoding 15,251 proteins. The genome contained 65 secondary metabolite gene clusters including 15 terpene synthases. Two terpenoid-associated gene clusters were identified containing sesterterpenoid synthase genes adjacent to cytochrome P450 enzyme genes. Genes involved in terpenoid biosynthesis were generally upregulated in mycelium, while polysaccharide biosynthesis-related genes were upregulated in the fruiting body.

Conclusion

This study provides the first complete genome sequence for a fungus in the Cyphellaceae family and reveals insights into the genetic basis of G. incarnatum’s medicinal properties. The identification of key genes and gene clusters involved in secondary metabolite production, particularly terpenoids and polysaccharides, lays a foundation for future characterization of bioactive compounds and pharmaceutical applications.
  • Published in:Genes (Basel),
  • Study Type:Genomic Analysis,
  • Source: 10.3390/genes10030188
Scroll to Top